Article
UGT2B7 372A>G Polymorphism Is Related To a Therapeutic Response to Lamotrigine Augmentation Therapy in Depressed Patients Who Did Not Respond to Adequate Treatment: A Preliminary Study
2022-01-17
Abstract excerpt
<title>Abstract</title> <p><bold>Purpose:</bold> Lamotrigine is mainly metabolized by UGT1A4 and UGT2B7, both of which are expressed in the blood–brain barrier. Polymorphisms of said <italic>UGTs</italic> that affect enzyme activities have been reported. This study investigated the relationship between these polymorphisms and its therapeutic effect in 55 depressed patients who did not respond to adequate treatmen...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b41a2a18-ddd1-58c3-a3d8-56e85f696493
- DOI
- 10.21203/rs.3.rs-1262527/v1
